Aconitase post-translational modification as a key in linkage between Krebs cycle, iron homeostasis, redox signaling, and metabolism of reactive oxygen species

Redox Report

Volumn 19, Issue 1, 2014, Pages 8-15

  Lushchak, Oleh V ^a   Piroddi, Marta ^b   Galli, Francesco ^b   Lushchak, Volodymyr I ^a  

^a VASYL STEFANYK PRECARPATHIAN NATIONAL UNIVERSITY   (Ukraine)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cellular metabolism; Iron regulatory protein 1; Posttranslational modification; Reactive oxygen species

Indexed keywords

ACONITATE HYDRATASE; REACTIVE OXYGEN METABOLITE;

AGING; CELL METABOLISM; CELL STRESS; CITRIC ACID CYCLE; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DENATURATION; ENZYME INACTIVATION; ENZYME REGULATION; HOMEOSTASIS; HUMAN; IRON METABOLISM; METABOLIC REGULATION; NITRATION; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW;

CELLULAR METABOLISM; IRON REGULATORY PROTEIN 1; POSTTRANSLATIONAL MODIFICATION; REACTIVE OXYGEN SPECIES;

ACONITATE HYDRATASE; AMINOACYLTRANSFERASES; ANIMALS; CITRIC ACID CYCLE; CYTOSOL; HOMEOSTASIS; IRON; ISOENZYMES; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84891867173     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000213Y.0000000073     Document Type: Review

References (76)

1. Velot C, Srere PA. Reversible transdominant inhibition of a metabolic pathway. In vivo evidence of interaction between two sequential tricarboxylic acid cycle enzymes in yeast. J Biol Chem 2000;275(17):12926-12933.
2. Sriram G, Martinez JA, McCabe ER, Liao JC, Dipple KM. Single-gene disorders: what role could moonlighting enzymes play? Am J Hum Genet 2005;76(6):911-924.
3. Rose IA, O'Connell EL. Mechanism of aconitase action. I. The hydrogen transfer reaction. J Biol Chem 1967;242(8):1870-1879.
4. Gardner PR, Fridovich I. Superoxide sensitivity of the Escherichia coli aconitase. J Biol Chem 1991;266(29):19328-19333.
5. Flint DH, Tuminello JF, Emptage MH. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J Biol Chem 1993; 268(30):22369-22376.
6. Bulteau AL, Ikeda-Saito M, Szweda LI. Redox-dependent modulation of aconitase activity in intact mitochondria. Biochemistry 2003;42(50):14846-14855.
7. Velsor LW, Kariya C, Kachadourian R, Day BJ. Mitochondrial oxidative stress in the lungs of cystic fibrosis transmembrane conductance regulator protein mutant mice. Am J Respir Cell Mol Biol 2006;35(5):579-586.
8. Gardner PR. Aconitase: sensitive target and measure of superoxide. Methods Enzymol 2002;349:9-23.
9. Lozinsky OV, Lushchak OV, Kryshchuk NI, Shchypanska NY, Riabkina AH, Skarbek SV, et al. S-nitrosoglutathione-induced toxicity in Drosophila melanogaster: delayed pupation and induced mild oxidative/nitrosative stress in eclosed flies. Comp Biochem Physiol A Mol Integr Physiol 2013;164(1):162-170.
10. Bota DA, Van Remmen H, Davies KJ. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 2002;532(1-2):103-106.
11. Zheng L, Kennedy MC, Blondin GA, Beinert H, Zalkin H. Binding of cytosolic aconitase to the iron responsive element of porcine mitochondrial aconitase mRNA. Arch Biochem Biophys 1992;299(2):356-360.
12. Bartosz G Reactive oxygen species: destroyers or messengers? Biochem Pharmacol 2009;77(8):1303-1315.
13. Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, et al. Melatonin signaling and cell protection function. Faseb J 2010;24(10):3603-3624.
14. Galli F, Cadenas E. Protein post-translational modifications in cell signaling and disease. Free Radic Res 2011;45(1):1-2.
15. Galli F Amino acid and protein modification by oxygen and nitrogen species. Amino Acids 2012;42(1):1-4.
16. Kim SY, Marekov L, Bubber P, Browne SE, Stavrovskaya I, Lee J, et al. Mitochondrial aconitase is a transglutaminase 2 substrate: transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem Res 2005;30(10):1245-1255.
17. Regev-Rudzki N, Karniely S, Ben-Haim NN, Pines O. Yeast aconitase in two locations and two metabolic pathways: seeing small amounts is believing. Mol Biol Cell 2005;16(9):4163-4171.
18. Chen XJ, Wang X, Butow RA. Yeast aconitase binds and provides metabolically coupled protection to mitochondrial DNA. Proc Natl Acad Sci USA 2007;104(34):13738-13743.
19. Cairo G, Recalcati S, Pietrangelo A, Minotti G The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 2002;32(12):1237-1243.
20. Anderson CP, Shen M, Eisenstein RS, Leibold EA. Mammalian iron metabolism and its control by iron regulatory proteins. Biochim Biophys Acta 2012;1823(9):1468-1483.
21. Cairo G, Ronchi R, Recalcati S, Campanella A, Minotti G Nitric oxide and peroxynitrite activate the iron regulatory protein-1 of J774A.1 macrophages by direct disassembly of the Fe-S cluster of cytoplasmic aconitase. Biochemistry 2002; 41(23):7435-7442.
22. Gehring NH, Hentze MW, Pantopoulos K. Inactivation of both RNA binding and aconitase activities of iron regulatory protein-1 by quinone-induced oxidative stress. J Biol Chem 1999;274(10): 6219-6225.
23. Lushchak VI. Free radical oxidation of proteins and its relationship with functional state of organisms. Biochemistry (Mosc) 2007;72(8):809-827.
24. Deck KM, Vasanthakumar A, Anderson SA, Goforth JB, Kennedy MC, Antholine WE, et al. Evidence that phosphoryl-ation of iron regulatory protein 1 at Serine 138 destabilizes the [4Fe-4S] cluster in cytosolic aconitase by enhancing 4Fe-3Fe cycling. J Biol Chem 2009;284(19):12701-12709.
25. Lu C, Cortopassi G. Frataxin knockdown causes loss of cyto-plasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. Arch Biochem Biophys 2007; 457(1):111-122.
26. Llorens JV, Navarro JA, Martínez-Sebastián MJ, Baylies MK, Schneuwly S, Botella JA, et al. Causative role of oxidative stress in a Drosophila model of Friedreich ataxia. FASEB J 2007;21(2):333-344.
27. Cheng Z, Tsuda M, Kishita Y, Sato Y, Aigaki T. Impaired energy metabolism in a Drosophila model of mitochondrial aco-nitase deficiency. Biochem Biophys Res Commun 2013;433(1): 145-150.
28. Bulteau AL, O'Neill HA, Kennedy MC, Ikeda-Saito M, Isaya G, Szweda LI. Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity. Science 2004; 305(5681):242-245.
29. Esposito G, Vos M, Vilain S, Swerts J, Valadas JDS, Van Meensel S, et al. Aconitase Causes Iron Toxicity in Drosophila pink1 Mutants. PLoS genetics 2013;9(4):1003478.
30. Wei YH, Wu SB, Ma YS, Lee HC. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med J 2009;32(2): 113-132.
31. Lushchak OV, Bayliak MM, Korobova OV, Levine RL, Lushchak VI. Buffer modulation of menadione-induced oxi-dative stress in Saccharomyces cerevisiae. Redox Rep 2009;4(5): 214-220.
32. Czerniczyniec A, Lores-Arnaiz S, Bustamante J. Mitochondrial susceptibility in a model of paraquat neurotoxicity. Free Radic Res 2013;47(8):614-623.
33. Lushchak OV, Lushchak VI. Catalase modifies yeast Saccharomyces cerevisiae response towards S-nitrosoglu-tathione-induced stress. Redox Rep 2008;13(6):283-291.
34. Lushchak OV, Lushchak VI. Sodium nitroprusside induces mild oxidative stress in Saccharomyces cerevisiae. Redox Rep 2008; 13(4):144-152.
35. Klinger H, Rinnerthaler M, Lam YT, Laun P, Heeren G, Klocker A, et al. Quantitation of (a)symmetric inheritance of functional and of oxidatively damaged mitochondrial aconitase in the cell division of old yeast mother cells. Exp Gerontol 2010;45(7-8):533-542.
36. Saraswathy S, Rao NA. Posttranslational modification of differentially expressed mitochondrial proteins in the retina during early experimental autoimmune uveitis. Mol Vis 2011;17: 1814-1821.
37. Unciuleac MC, Chandramouli K, Naik S, Mayer S, Huynh BY, Johnson MK, et al. In vitro activation of apo-aconitase using a [4Fe-4S] cluster-loaded form of the IscU [Fe-S] cluster scaffolding protein. Biochemistry 2007;46(23):6812-6821.
38. Schwartz CJ, Djaman O, Imlay JA, Kiley PJ. The cysteine desul-furase, IscS, has a major role in in vivo Fe-S cluster formation in Escherichia coli. Proc Natl Acad Sci USA 2000;97(16):9009-14.
39. Sheftel AD, Wilbrecht C, Stehling O, Niggemeyer B, Elsässer HP, Mühlenhoff U, Lill R. The human mitochondrial ISCA1, ISCA2, and IBA57 proteins are required for [4Fe-4S] protein maturation. Mol Biol Cell 2012;23(7):1157-1166.
40. Claiborne A, Yeh JI, Mallett TC, Luba J, Crane EJ, III, Charrier V, et al. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 1999; 38(47):15407-15416.
41. Lushchak VI. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012;2012, ID 736837:26.
42. Cheung PY, Danial H, Jong J, Schulz R. Thiols protect the inhibition of myocardial aconitase by peroxynitrite. Arch Biochem Biophys 1998;350(1):104-108.
43. Biteau B, Labarre J, Toledano MB. ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 2003;425(6961):980-984.
44. Hahm KS, Gawron O, Piszkiewicz D. Amino acid sequence of a peptide containing an essential cysteine residue of pig heart aco-nitase. Biochim Biophys Acta 1981;667(2):457-461.
45. Han D, Canali R, Garcia J, Aguilera R, Gallaher TK, Cadenas E. Sites and mechanisms of aconitase inactivation by peroxyni-trite: modulation by citrate and glutathione. Biochemistry 2005;44(36):11986-11996.
46. Bota DA, Davies KJ. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 2002;4(9):674-680.
47. Ugarte N, Petropoulos I, Friguet B. Oxidized mitochondrial protein degradation and repair in aging and oxidative stress. Antioxid Redox Signal 2010;13(4):539-549.
48. Galli F, Piroddi M, Annetti C, Aisa C, Floridi E, Floridi A. Oxidative stress and reactive oxygen species. Contrib Nephrol 2005;149:240-260.
49. Liu Q, Simpson DC, Gronert S. Carbonylation of mitochondrial aconitase with 4-hydroxy-2-(E)-nonenal: localization and relative reactivity of addition sites. Biochim Biophys Acta 2013; 1834(6):1144-1154.
50. Yan LJ, Levine RL, Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci USA 1997;94(21):11168-11172.
51. Yarian CS, Toroser D, Sohal RS. Aconitase is the main functional target of aging in the citric acid cycle of kidney mitochondria from mice. Mech Ageing Dev 2006;127(1):9-84.
52. Yarian CS, Rebrin I, Sohal RS. Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria. Biochem Biophys Res Commun 2005;330(1):151-156.
53. Prokai L, Yan LJ, Vera-Serrano JL, Stevens SM Jr, Forster MJ. Mass spectrometry-based survey of age-associated protein carbo-nylation in rat brain mitochondria. J Mass Spectrom 2007; 42(12):1583-1589.
54. Zhu J, Chu CT. Mitochondrial dysfunction in Parkinson's disease. J Alzheimers Dis 2010;20(Suppl 2):325-334.
55. Cacciatore I, Baldassarre L, Fornasari E, Mollica A, Pinnen F. Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems. Oxid Med Cell Longev 2012; 2012, ID 240146:12.
56. Raukas M, Rebane R, Mahlapuu R, Jefremov V, Zilmer K, Karelson E, et al. Mitochondrial oxidative stress index, activity of redox-sensitive aconitase and effects of endogenous anti-and pro-oxidants on its activity in control, Alzheimer's disease and Swedish Familial Alzheimer's disease brain. Free Radic Res 2012;46(12):1490-1495.
57. Baron M, Kudin AP, Kunz WS. Mitochondrial dysfunction in neurodegenerative disorders. Biochem Soc Trans 2007;35(Pt 5): 1228-1231.
58. Perluigi M, Sultana R, Cenini G, Di Domenico F, Memo M, Pierce WM, et al. Redox proteomics identification of 4-hydroxy-nonenal-modified brain proteins in Alzheimer's disease: role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin Appl 2009;3(6):682-693.
59. Reed TT, Pierce WM, Markesbery WR, Butterfield DA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Res 2009;1274:66-76.
60. Hecker PA, Lionetti V, Ribeiro RF Jr, Rastogi S, Brown BH, O'Connell KA, et al. Glucose 6-phosphate dehydrogenase deficiency increases redox stress and moderately accelerates the development of heart failure. Circ Heart Fail 2013;6(1): 118-126.
61. Hunzinger C, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Zengerling H, et al. Comparative profiling of the mammalian mitochondrial proteome: multiple aconitase-2 isoforms including N-formylkynurenine modifications as part of a protein bio-marker signature for reactive oxidative species. J Proteome Res 2006;5(3):625-633.
62. Galli F. Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant 2007;22:20-36.
63. Piroddi M, Palmese A, Pilolli F, Amoresano A, Pucci P, Ronco C, et al. Plasma nitroproteome of kidney disease patients. Amino Acids 2011;40(2):653-667.
64. Tyther R, McDonagh B, Sheehan D. Proteomics in investigation of protein nitration in kidney disease: technical challenges and perspectives from the spontaneously hypertensive rat. Mass Spectrom Rev 2011;30(1):121-141.
65. Bhattacharjee A, Majumdar U, Maity D, Sarkar TS, Goswami AM, Sahoo R, et al. In vivo protein tyrosine nitration in S. cerevisiae: identification of tyrosine-nitrated proteins in mitochondria. Biochem Biophys Res Commun 2009;388(3):612-617.
66. Missall TA, Pusateri ME, Donlin MJ, Chambers KT, Corbett JA, Lodge JK. Posttranslational, translational, and transcriptional responses to nitric oxide stress in Cryptococcus neofor-mans: implications for virulence. Eukaryot Cell 2006;5(3): 518-529.
67. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci USA 1996;93(16):8175-8182.
68. Bouton C, Hirling H, Drapier JC. Redox modulation of iron regulatory proteins by peroxynitrite. J Biol Chem 1997;272(32): 19969-19975.
69. Soum E, Brazzolotto X, Goussias C, Bouton C, Moulis JM, Mattioli TA, et al. Peroxynitrite and nitric oxide differently target the iron-sulfur cluster and amino acid residues of human iron regulatory protein 1. Biochemistry 2003;42(25):7648-7454.
70. Zumbrennen KB, Wallander ML, Romney SJ, Leibold EA. Cysteine oxidation regulates the RNA-binding activity of iron regulatory protein 2. Mol Cell Biol 2009;29(8):2219-2229.
71. Eisenstein RS, Tuazon PT, Schalinske KL, Anderson SA, Traugh JA. Iron-responsive element-binding protein. Phosphorylation by protein kinase C. J Biol Chem 1993; 268(36):27363-27370.
72. Pitula JS, Deck KM, Clarke SL, Anderson SA, Vasanthakumar A, Eisenstein RS. Selective inhibition of the citrate-to-isocitrate reaction of cytosolic aconitase by phosphomimetic mutation of serine-711. Proc Natl Acad Sci USA 2004;101(30):10907-10912.
73. Lin G, Brownsey RW, MacLeod KM. Regulation of mitochondrial aconitase by phosphorylation in diabetic rat heart. Cell Mol Life Sci 2009;66(5):919-932.
74. Salvi M, Morrice NA, Brunati AM, Toninello A. Identification of the flavoprotein of succinate dehydrogenase and aconitase as in vitro mitochondrial substrates of Fgr tyrosine kinase. FEBS Lett 2007;581(29):5579-5585.
75. Gannon J, Staunton L, O'Connell K, Doran P, Ohlendieck K. Phosphoproteomic analysis of aged skeletal muscle. Int J Mol Med 2008;22(1):33-42.
76. Correa F, Buelna-Chontal M, Hernández-Reséndiz S, García-Niño WR, J Roldán F, Soto V, et al. Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Free Radic Biol Med 2013;61C:119-129